Structure of sybody MR17 in complex with the SARS-CoV-2 S receptor-binding domain (RBD)

Summary for 7C8W

DescriptorSynthetic nanobody MR17, Spike glycoprotein, N-ACETYL-D-GLUCOSAMINE, ... (5 entities in total)
Functional Keywordscoronavirus, covid-19, nanobody, neutralizing antibody, receptor binding protein, sars-cov-2, s protein, synthetic antibody, vhh., protein binding
Biological sourcesynthetic construct
Total number of polymer chains2
Total molecular weight38044.3
Li, T.,Cai, H.,Yao, H.,Qin, W.,Li, D. (deposition date: 2020-06-03, release date: 2020-06-24)
Primary citation
Li, T.,Cai, H.,Yao, H.,Zhou, B.,Zhao, Y.,Qin, W.,Lavillette, D.,Li, D.
Rapid selection of synthetic nanobodies against the receptor binding domain of SARS-CoV-2 S protein
To Be Published,
Experimental method

Structure validation

RfreeClashscoreRamachandran outliersSidechain outliersRSRZ outliers 0.26780 1.9% 4.4%MetricValuePercentile RanksWorseBetterPercentile relative to all X-ray structuresPercentile relative to X-ray structures of similar resolution
Download full validation reportDownload